Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome.

Giacomini A, Stagni F, Emili M, Guidi S, Salvalai ME, Grilli M, Vidal-Sanchez V, Martinez-Cué C, Bartesaghi R.

Brain Res Bull. 2018 Jun;140:378-391. doi: 10.1016/j.brainresbull.2018.06.009. Epub 2018 Jun 20.

PMID:
29935232
2.

Abnormal development of the inferior temporal region in fetuses with Down syndrome.

Guidi S, Giacomini A, Stagni F, Emili M, Uguagliati B, Bonasoni MP, Bartesaghi R.

Brain Pathol. 2018 Mar 6. doi: 10.1111/bpa.12605. [Epub ahead of print]

PMID:
29509279
3.

Late-Onset Hepatic Veno-Occlusive Disease after Allografting: Report of Two Cases with Atypical Clinical Features Successfully Treated with Defibrotide.

Castellino A, Guidi S, Dellacasa CM, Gozzini A, Donnini I, Nozzoli C, Manetta S, Aydin S, Giaccone L, Festuccia M, Brunello L, Maffini E, Bruno B, David E, Busca A.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018001. doi: 10.4084/MJHID.2018.001. eCollection 2018.

4.

Complexity in internal medicine wards: A novel screening method and implications for management.

Bandini F, Guidi S, Blaszczyk S, Fumarulo A, Pierini M, Pratesi P, Spolveri S, Padeletti M, Petrone P, Zoppi P, Landini G.

J Eval Clin Pract. 2018 Feb;24(1):285-292. doi: 10.1111/jep.12875. Epub 2018 Jan 10.

PMID:
29318709
5.

Access to alternative donor hematopoietic search and transplantation for acute leukemia in different macro-regions of Italy. A GITMO/IBMDR study.

Milone G, Sacchi N, Gallina A, Leotta S, Picardi A, Guidi S, Tripepi G, Rambaldi A, Bonifazi F.

Bone Marrow Transplant. 2018 Mar;53(3):291-299. doi: 10.1038/s41409-017-0026-z. Epub 2017 Dec 21.

PMID:
29269809
6.

Different contexts change the impression of animacy.

Parovel G, Guidi S, Kreß K.

Atten Percept Psychophys. 2018 Feb;80(2):553-563. doi: 10.3758/s13414-017-1439-x.

PMID:
29181761
7.

'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Giaccone L, Mancini G, Mordini N, Gargiulo G, De Cecco V, Angelini S, Arpinati M, Baronciani D, Bozzoli V, Bramanti S, Calore E, Cavattoni IM, Cimminiello M, Colombo AA, Facchini L, Falcioni S, Faraci M, Fedele R, Guidi S, Iori AP, Marotta S, Micò MC, Milone G, Onida F, Pastore D, Patriarca F, Pini M, Raimondi R, Rovelli A, Santarone S, Severino A, Skert C, Stanghellini MTL, Tecchio C, Vassallo E, Chiarucci M, Bruno B, Bonifazi F, Olivieri A.

Bone Marrow Transplant. 2018 Jan;53(1):58-63. doi: 10.1038/bmt.2017.223. Epub 2017 Oct 30.

PMID:
29084200
8.

Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.

Girmenia C, Bertaina A, Piciocchi A, Perruccio K, Algarotti A, Busca A, Cattaneo C, Raiola AM, Guidi S, Iori AP, Candoni A, Irrera G, Milone G, Marcacci G, Scimè R, Musso M, Cudillo L, Sica S, Castagna L, Corradini P, Marchesi F, Pastore D, Alessandrino EP, Annaloro C, Ciceri F, Santarone S, Nassi L, Farina C, Viscoli C, Rossolini GM, Bonifazi F, Rambaldi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO) and Associazione Microbiologi Clinici Italiani (AMCLI).

Clin Infect Dis. 2017 Nov 13;65(11):1884-1896. doi: 10.1093/cid/cix690.

9.

A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.

Stagni F, Giacomini A, Guidi S, Emili M, Uguagliati B, Salvalai ME, Bortolotto V, Grilli M, Rimondini R, Bartesaghi R.

Exp Neurol. 2017 Dec;298(Pt A):79-96. doi: 10.1016/j.expneurol.2017.08.018. Epub 2017 Sep 4.

PMID:
28882412
10.

Targeting APP/AICD in Down syndrome.

Guidi S, Stagni F, Bartesaghi R.

Oncotarget. 2017 Jun 30;8(31):50333-50334. doi: 10.18632/oncotarget.18860. eCollection 2017 Aug 1. No abstract available.

11.

Neurogenesis impairment: An early developmental defect in Down syndrome.

Stagni F, Giacomini A, Emili M, Guidi S, Bartesaghi R.

Free Radic Biol Med. 2018 Jan;114:15-32. doi: 10.1016/j.freeradbiomed.2017.07.026. Epub 2017 Jul 27. Review.

PMID:
28756311
12.

Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.

Roncacé V, Burattini C, Stagni F, Guidi S, Giacomini A, Emili M, Aicardi G, Bartesaghi R.

Neurobiol Dis. 2017 Oct;106:89-100. doi: 10.1016/j.nbd.2017.06.017. Epub 2017 Jun 23.

PMID:
28651891
13.

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

Kröger N, Iacobelli S, Franke GN, Platzbecker U, Uddin R, Hübel K, Scheid C, Weber T, Robin M, Stelljes M, Afanasyev B, Heim D, Deliliers GL, Onida F, Dreger P, Pini M, Guidi S, Volin L, Günther A, Bethge W, Poiré X, Kobbe G, van Os M, Brand R, de Witte T.

J Clin Oncol. 2017 Jul 1;35(19):2157-2164. doi: 10.1200/JCO.2016.70.7349. Epub 2017 May 2.

PMID:
28463633
14.

Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome.

Stagni F, Raspanti A, Giacomini A, Guidi S, Emili M, Ciani E, Giuliani A, Bighinati A, Calzà L, Magistretti J, Bartesaghi R.

Neurobiol Dis. 2017 Jul;103:11-23. doi: 10.1016/j.nbd.2017.03.012. Epub 2017 Mar 28.

15.

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

Della Porta MG, Jackson CH, Alessandrino EP, Rossi M, Bacigalupo A, van Lint MT, Bernardi M, Allione B, Bosi A, Guidi S, Santini V, Malcovati L, Ubezio M, Milanesi C, Todisco E, Voso MT, Musto P, Onida F, Iori AP, Cerretti R, Grillo G, Molteni A, Pioltelli P, Borin L, Angelucci E, Oldani E, Sica S, Pascutto C, Ferretti V, Santoro A, Bonifazi F, Cazzola M, Rambaldi A.

Leukemia. 2017 Nov;31(11):2449-2457. doi: 10.1038/leu.2017.88. Epub 2017 Mar 21.

16.

Epigallocatechin gallate: A useful therapy for cognitive disability in Down syndrome?

Stagni F, Giacomini A, Emili M, Guidi S, Ciani E, Bartesaghi R.

Neurogenesis (Austin). 2017 Feb 2;4(1):e1270383. doi: 10.1080/23262133.2016.1270383. eCollection 2017.

17.

Ionic liquids as transesterification catalysts: applications for the synthesis of linear and cyclic organic carbonates.

Selva M, Perosa A, Guidi S, Cattelan L.

Beilstein J Org Chem. 2016 Aug 26;12:1911-1924. eCollection 2016. Review.

18.

Fully automated, clinical-grade bone marrow processing: a single-centre experience.

Mazzanti B, Urbani S, Dal Pozzo S, Bufano P, Ballerini L, Gelli A, Sodi I, Donnini I, Di Gioia M, Guidi S, Camisani J, Saccardi R.

Blood Transfus. 2017 Oct;15(6):577-584. doi: 10.2450/2016.0057-16. Epub 2016 Sep 27.

19.

Lithium Restores Age-related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome.

Guidi S, Bianchi P, Stagni F, Giacomini A, Emili M, Trazzi S, Ciani E, Bartesaghi R.

CNS Neurol Disord Drug Targets. 2017;16(7):812-819. doi: 10.2174/1871527315666160801143108.

PMID:
27488422
20.

Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.

Stagni F, Giacomini A, Emili M, Trazzi S, Guidi S, Sassi M, Ciani E, Rimondini R, Bartesaghi R.

Neuroscience. 2016 Oct 1;333:277-301. doi: 10.1016/j.neuroscience.2016.07.031. Epub 2016 Jul 25.

PMID:
27457036
21.

Illusory Streaks from Corners and Their Perceptual Integration.

Roncato S, Guidi S, Parlangeli O, Battaglini L.

Front Psychol. 2016 Jun 23;7:959. doi: 10.3389/fpsyg.2016.00959. eCollection 2016.

22.
23.

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.

Kröger N, Solano C, Wolschke C, Bandini G, Patriarca F, Pini M, Nagler A, Selleri C, Risitano A, Messina G, Bethge W, Pérez de Oteiza J, Duarte R, Carella AM, Cimminiello M, Guidi S, Finke J, Mordini N, Ferra C, Sierra J, Russo D, Petrini M, Milone G, Benedetti F, Heinzelmann M, Pastore D, Jurado M, Terruzzi E, Narni F, Völp A, Ayuk F, Ruutu T, Bonifazi F.

N Engl J Med. 2016 Jan 7;374(1):43-53. doi: 10.1056/NEJMoa1506002.

24.

Timing of therapies for Down syndrome: the sooner, the better.

Stagni F, Giacomini A, Guidi S, Ciani E, Bartesaghi R.

Front Behav Neurosci. 2015 Oct 6;9:265. doi: 10.3389/fnbeh.2015.00265. eCollection 2015. Review.

25.

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial.

Rambaldi A, Grassi A, Masciulli A, Boschini C, Micò MC, Busca A, Bruno B, Cavattoni I, Santarone S, Raimondi R, Montanari M, Milone G, Chiusolo P, Pastore D, Guidi S, Patriarca F, Risitano AM, Saporiti G, Pini M, Terruzzi E, Arcese W, Marotta G, Carella AM, Nagler A, Russo D, Corradini P, Alessandrino EP, Torelli GF, Scimè R, Mordini N, Oldani E, Marfisi RM, Bacigalupo A, Bosi A.

Lancet Oncol. 2015 Nov;16(15):1525-1536. doi: 10.1016/S1470-2045(15)00200-4. Epub 2015 Sep 28.

26.

Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome.

Giacomini A, Stagni F, Trazzi S, Guidi S, Emili M, Brigham E, Ciani E, Bartesaghi R.

Neurobiol Dis. 2015 Oct;82:385-396. doi: 10.1016/j.nbd.2015.08.001. Epub 2015 Aug 5.

27.

[In-depth assessment of work-related stress in a major company undergoing restructuring].

Magrini A, Pelagalli MF, Pietroiusti A, Livigni L, Guidi S, Moscatelli M, Mascioli M, D'Orsi F, Zolla A, Bagnara S.

Med Lav. 2015 Jul 8;106(4):250-60. Italian.

PMID:
26154468
28.

The psychophysics of comic: Effects of incongruity in causality and animacy.

Parovel G, Guidi S.

Acta Psychol (Amst). 2015 Jul;159:22-32. doi: 10.1016/j.actpsy.2015.05.002. Epub 2015 May 27.

PMID:
26010066
29.

Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease.

Piñana JL, Sanz J, Esquirol A, Martino R, Picardi A, Barba P, Parody R, Gayoso J, Montesinos P, Guidi S, Terol MJ, Moscardó F, Solano C, Arcese W, Sanz MA, Sierra J, Sanz G; GETH GITMO groups.

Eur J Haematol. 2016 Feb;96(2):128-35. doi: 10.1111/ejh.12557. Epub 2015 Apr 18.

PMID:
25845981
30.

Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application.

Torre ML, Lucarelli E, Guidi S, Ferrari M, Alessandri G, De Girolamo L, Pessina A, Ferrero I; Gruppo Italiano Staminali Mesenchimali (GISM).

Stem Cells Dev. 2015 Mar 15;24(6):677-85. doi: 10.1089/scd.2014.0299. Epub 2015 Feb 5.

31.

Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.

Stagni F, Giacomini A, Guidi S, Ciani E, Ragazzi E, Filonzi M, De Iasio R, Rimondini R, Bartesaghi R.

Neurobiol Dis. 2015 Feb;74:204-18. doi: 10.1016/j.nbd.2014.12.005. Epub 2014 Dec 10.

PMID:
25497735
32.

Sleep-readiness signals in insomniacs and good sleepers.

Giganti F, Guidi S, Aboudan S, Baiardi S, Mondini S, Cirignotta F, Salzarulo P.

J Health Psychol. 2016 May;21(5):661-8. doi: 10.1177/1359105314535124. Epub 2014 Jun 8.

PMID:
24913008
33.

Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Girmenia C, Raiola AM, Piciocchi A, Algarotti A, Stanzani M, Cudillo L, Pecoraro C, Guidi S, Iori AP, Montante B, Chiusolo P, Lanino E, Carella AM, Zucchetti E, Bruno B, Irrera G, Patriarca F, Baronciani D, Musso M, Prete A, Risitano AM, Russo D, Mordini N, Pastore D, Vacca A, Onida F, Falcioni S, Pisapia G, Milone G, Vallisa D, Olivieri A, Bonini A, Castagnola E, Sica S, Majolino I, Bosi A, Busca A, Arcese W, Bandini G, Bacigalupo A, Rambaldi A, Locasciulli A.

Biol Blood Marrow Transplant. 2014 Jun;20(6):872-80. doi: 10.1016/j.bbmt.2014.03.004. Epub 2014 Mar 14.

34.

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.

Della Porta MG, Alessandrino EP, Bacigalupo A, van Lint MT, Malcovati L, Pascutto C, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Bernasconi P, Bosi A, Cazzola M, Rambaldi A; Gruppo Italiano Trapianto di Midollo Osseo.

Blood. 2014 Apr 10;123(15):2333-42. doi: 10.1182/blood-2013-12-542720. Epub 2014 Feb 20.

35.

Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.

Guidi S, Stagni F, Bianchi P, Ciani E, Giacomini A, De Franceschi M, Moldrich R, Kurniawan N, Mardon K, Giuliani A, Calzà L, Bartesaghi R.

Brain. 2014 Feb;137(Pt 2):380-401. doi: 10.1093/brain/awt340. Epub 2013 Dec 12.

PMID:
24334313
36.

Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome.

Bianchi P, Bettini S, Guidi S, Ciani E, Trazzi S, Stagni F, Ragazzi E, Franceschini V, Bartesaghi R.

Exp Neurol. 2014 Jan;251:1-11. doi: 10.1016/j.expneurol.2013.10.018. Epub 2013 Nov 2.

PMID:
24192151
37.

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation.

Martínez C, Canals C, Sarina B, Alessandrino EP, Karakasis D, Pulsoni A, Sica S, Trneny M, Snowden JA, Kanfer E, Milpied N, Bosi A, Guidi S, de Souza CA, Willemze R, Arranz R, Jebavy L, Hellmann A, Sibon D, Oneto R, Luan JJ, Dreger P, Castagna L, Sureda A; Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (EBMT) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Ann Oncol. 2013 Sep;24(9):2430-4. doi: 10.1093/annonc/mdt206. Epub 2013 May 26.

PMID:
23712545
38.

Pharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndrome.

Stagni F, Magistretti J, Guidi S, Ciani E, Mangano C, Calzà L, Bartesaghi R.

PLoS One. 2013 Apr 19;8(4):e61689. doi: 10.1371/journal.pone.0061689. Print 2013.

39.

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.

Alessandrino EP, Porta MG, Malcovati L, Jackson CH, Pascutto C, Bacigalupo A, Teresa van Lint M, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Rambaldi A, Bosi A, Cazzola M; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Am J Hematol. 2013 Jul;88(7):581-8. doi: 10.1002/ajh.23458. Epub 2013 May 30.

40.

Yawning: a behavioural marker of sleepiness in de novo PD patients.

Giganti F, Guidi S, Ramat S, Zilli I, Raglione LM, Sorbi S, Salzarulo P.

Parkinsonism Relat Disord. 2013 Jul;19(7):703-4. doi: 10.1016/j.parkreldis.2013.03.007. Epub 2013 Apr 18. No abstract available.

PMID:
23602320
41.

Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry.

Passera R, Pollichieni S, Brunello L, Patriarca F, Bonifazi F, Montefusco V, Falda M, Montanari M, Guidi S, Giaccone L, Mordini N, Carella AM, Bavaro P, Milone G, Benedetti F, Ciceri F, Scimè R, Benedetti E, Castagna L, Festuccia M, Rambaldi A, Bacigalupo A, Corradini P, Bosi A, Boccadoro M, Bandini G, Fanin R, Bruno B.

Biol Blood Marrow Transplant. 2013 Jun;19(6):940-8. doi: 10.1016/j.bbmt.2013.03.012. Epub 2013 Mar 26.

42.

Daytime course of sleepiness in de novo Parkinson's disease patients.

Giganti F, Ramat S, Zilli I, Guidi S, Raglione LM, Sorbi S, Salzarulo P.

J Sleep Res. 2013 Apr;22(2):197-200. doi: 10.1111/jsr.12000. Epub 2012 Nov 9.

43.

Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor.

Milone G, Tripepi G, Martino M, Ancora F, Bartolozzi B, Spadaro A, Nozzoli C, La Fauci A, Amico I, Leotta S, Poidomani M, Irrera G, Iacopino P, Saccardi R, Guidi S, Bosi A.

Blood Transfus. 2013 Jan;11(1):94-101. doi: 10.2450/2012.0004-12. Epub 2012 Oct 10.

44.

The collaborative communication model for patient handover at the interface between high-acuity and low-acuity care.

Toccafondi G, Albolino S, Tartaglia R, Guidi S, Molisso A, Venneri F, Peris A, Pieralli F, Magnelli E, Librenti M, Morelli M, Barach P.

BMJ Qual Saf. 2012 Dec;21 Suppl 1:i58-66. doi: 10.1136/bmjqs-2012-001178. Epub 2012 Oct 25.

45.

Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression.

Fuchs C, Ciani E, Guidi S, Trazzi S, Bartesaghi R.

Lab Invest. 2012 Nov;92(11):1648-60. doi: 10.1038/labinvest.2012.117. Epub 2012 Aug 13.

46.

Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome.

Guidi S, Stagni F, Bianchi P, Ciani E, Ragazzi E, Trazzi S, Grossi G, Mangano C, Calzà L, Bartesaghi R.

Brain Pathol. 2013 Mar;23(2):129-43. doi: 10.1111/j.1750-3639.2012.00624.x. Epub 2012 Sep 3.

PMID:
22817700
47.

Acute encephalopathy in the immune-compromised child: never forget toxoplasmosis.

Caselli D, Andreoli E, Paolicchi O, Savelli S, Guidi S, Pecile P, Aricò M.

J Pediatr Hematol Oncol. 2012 Jul;34(5):383-6. doi: 10.1097/MPH.0b013e318257a15c.

PMID:
22627571
48.

The HSE indicator tool, psychological distress and work ability.

Guidi S, Bagnara S, Fichera GP.

Occup Med (Lond). 2012 Apr;62(3):203-9. doi: 10.1093/occmed/kqs021. Epub 2012 Mar 6.

PMID:
22394682
49.

A mind in a disk: the attribution of mental states to technological systems.

Parlangeli O, Chiantini T, Guidi S.

Work. 2012;41 Suppl 1:1118-23. doi: 10.3233/WOR-2012-0291-1118.

PMID:
22316869
50.

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.

Rigacci L, Puccini B, Dodero A, Iacopino P, Castagna L, Bramanti S, Ciceri F, Fanin R, Rambaldi A, Falda M, Milone G, Guidi S, Martelli MF, Mazza P, Oneto R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Ann Hematol. 2012 Jun;91(6):931-9. doi: 10.1007/s00277-011-1395-9. Epub 2012 Jan 14.

PMID:
22245922

Supplemental Content

Support Center